Femtobiomed (XKRX:327610) ROCE % : 0.00% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Femtobiomed's annualized ROCE % for the quarter that ended in Dec. 2024 was 0.00%.

Femtobiomed ROCE % Historical Data

The historical data trend for Femtobiomed's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed ROCE % Chart

Femtobiomed Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-109.11

Femtobiomed Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
ROCE %	Get a 7-Day Free Trial			-109.11	-	-	-	-

Femtobiomed ROCE % Calculation

Femtobiomed's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-5321.979	/	( ( (3287.193 - 11987.741)	+	(3548.666 - 14608.971) )	/ 2 )
	=	-5321.979	/	( (-8700.548	+	-11060.305)	/ 2 )
	=	-5321.979	/	-9880.4265
	=	53.86 %

Femtobiomed's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Dec. 2023 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Dec. 2023 )		(Q: Dec. 2024 )
	=	-5321.979	/	( ( (3287.193 - 11987.741)	+	(3548.666 - 14608.971) )	/ 2 )
	=	-5321.979	/	( ( -8700.548	+	-11060.305 )	/ 2 )
	=	-5321.979	/	-9880.4265
	=	0 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

Femtobiomed (XKRX:327610) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Femtobiomed ROCE % Related Terms

Thank you for viewing the detailed overview of Femtobiomed's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Femtobiomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

https://www.femtobiomed.com

Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines